Tue, Dec 23, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Better to have best managers in unattractive strategies than mediocre managers in best strategies

Wednesday, October 16, 2013

amb
Umberto Boccato
Benedicte Gravrand, Opalesque Geneva:

Umberto Boccato, CIO of Alternative Investments at Mirabaud, an international financial group that offers private banking and asset management services, talks to Opalesque from his Geneva offices about the company’s funds of hedge funds.

Mirabaud was one of the first Swiss banking establishments in the 1970s to invest in hedge funds. Its Asset Management unit is one of those funds of hedge funds firms that don’t just run funds of hedge funds but also offer advisory and recommendations and due diligence services as well as specific mandates and managed accounts. It manages $5 billion of which $2.5 billion are through funds of hedge funds or managed accounts. Five funds of hedge funds invest in 120 underlying funds, and are managed by a team of 20.

Umberto Boccato: The common underlying theme of our product is, we see them more as a vehicle to give access to our clients to what we think some of the best talented managers. And what we favour in terms of managers is obviously experience. The other feature that we look for is alignment of interest, so we welcome a lot of managers who put their personal wealth in the fund; they are much more focused on compounding their wealth rather than just seeking to gather assets.

Opalesque: Yes, and you also select managers ......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its